**Specifications Table**TableSubject area*Microbiology, Parasitology*More specific subject area*Malaria Diagnosis and Control*Type of data*Table*How data was acquired*Microscopy; Rapid Diagnostic Methods*Data format*Raw, Analyzed data in tables*Experimental factors*Ethical approval obtained from BIOSREC, Consent and accent sought*Experimental features*Blood samples obtained from febrile and non-febrile subjects visiting the selected health centers and tested for malaria using different methods*Data source location*Ado Odo/Ota, Ogun State, Nigeria*Data accessibility*Data is available in article*Related research articleDozie and Chukwuocha [@bib4]*Comparative Evaluation of Malaria Rapid Diagnostic Test Kits Commercially Available in Parts of South Eastern Nigeria J Trop Dis 04(02)*[@bib4]

**Value of the data**•Data provided here could inform the quality and choice of Rapid Diagnostic Test (RDT) in malaria endemic regions.•Data presented here, when compared with data from other regions, could be used to measure the efficacy of RDTs vis-à-vis the malaria control agenda.•Data provided may inform the development of cheap and non-invasive diagnostic method for malaria.

1. Data {#s0005}
=======

[Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"} present data from diagnosis using the RDT kits as well as microscopy among asymptomatic participants. The tables contain the counts for total number of participants alongside the number that tested positive. [Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"}, [Table 7](#t0035){ref-type="table"}, [Table 8](#t0040){ref-type="table"} present results obtained for the RDTs and microscopy among participants who were symptomatic i.e. had a fever ≥ 37.5 °C. [Table 9](#t0045){ref-type="table"}, [Table 10](#t0050){ref-type="table"}, [Table 11](#t0055){ref-type="table"}, [Table 12](#t0060){ref-type="table"} contains a summary assessment of both RDT kits tested, using microscopy as baseline).Table 1Incidence of *P. falciparum* using Bioline SD kits among asymptomatic carriers.Table 1Age group in yearsNo of samples collectedNo of positive samples on kit (BIOLINE SD)MaleFemaleTotalMaleFemaleTotal0--5354378913226--111091921312--1761117--3318--238122011224--29121931--2230171835112Total (%)88 (44)112 (66)200 (100)13 (6.5)21 (10.5)34 (17)Table 2Incidence of *P. falciparum* using ACON kits among asymptomatic carriers.Table 2Age group in yearsNo of samples collectedNo of positive samples in kit (ACON)MaleFemaleTotalMalefemaleTotal0--535437868146--111091933612--1761117--4418--238122022424--2912193114530171835--33Total (%)88 (44)112 (66)200 (100)12 (6)24(12)36(18)Table 3Incidence of *P. falciparum* using microscopic method among asymptomatic carriers.Table 3No of samples collectedNo of positive samplesMaleFemaleTotalMaleFemaleTotal0--53543781216286--111091923512--176111743718--238122034724--29121931--4430171835112Total (%)88 (44)112 (66)200 (100)22 (11)31 (15.5)53 (26.5)Table 4Comparative incidence rates of malaria among asymptomatic subjects using ACON, Bioline SD kits and microscopy.Table 4SexNumber of sample collected (%)Number of Positive samples (%)MicroscopyBioline SDACONMale88 (44)22 (25)13 (14.8)12(13.6)Female112 (56)31 (27.7)21 (18.8)24(21.4)Total200 (100)53 (26.5)34 (17)36(18)Table 5Incidence of *P. falciparum* and *P. vivax* using ACON RDT kit among symptomatic subjects.Table 5Age group in yearsNumber of samples collectedNumber of positive samplesMaleFemaleTotalMaleFemaleTotalP.fP.vP.fP.vP.fP.v0--51--1------------6--101121------1--11--15--441------1--16--20111627729--16221--253472--1--3--\>2691019----2--2--Total25 (41.7)35 (58.3)60 (100)11 (47.8)2(100)12(52.2)-(-)23(100)2(100)Table 6Incidence of *P. falciparum* using Bioline SD kits among symptomatic subjects.Table 6Age group in yearsNumber of samples collectedNumber of positive samplesMaleFemaleTotalMaleFemaleTotal0--51--1------6--101121--111--15--4411216--20111627791621--25347213\>2691019--22Total25(41.7)35(58.3)60(100)11 (45.8)13(54.2)24(100)Table 7Incidence of *P. falciparum* and *P. vivax* using microscopy among symptomatic subjects.Table 7Age group in yearsNumber of samples collectedNumber of Positive samplesMaleFemaleTotalMaleFemaleTotal0--51--11--16--101121--111--15--44------16--201116271091921--25347------\>26910194--4Total25(41.7)35(58.3)60 (100)16(64)9 (36)25 (100)Table 8Incidence of malaria using ACON kits, Bioline SD kits and microscopy among symptomatic subjects.Table 8SexNumber of samples collected (%)Number of Positive Samples (%)Microscopy (%)RDTsACONBioline SD (HRP-2) (%)HRP-2 (%)Pan-Aldolase (%)Male25 (41.7)16 (64)11 (44)2 (8)11 (44)Female35 (58.3)9 (25.7)12 (34.3)--13 (37.1)Total60 (100)25 (41.7)23(38)2 (3.3)24 (40)Table 9Performance of microscopy and RDTs across both cohorts.Table 9**Symptomatic Cohort N=60Asymptomatic Cohort N=200**PositiveNegativePrevalenceSensitivity (95% CI)Fishers P valueκ valuePositiveNegativePrevalenceSensitivity (95% CI)Fishers P valueκ value                          SD Bioline243640%96% (0.7965--0.990)\<0.00010.9663416664.15%64.15% (0.4980--0.7686)\<0.00010.725ACON253541.67%100% (0.8628--1.000)\<0.00011.0003616418%67.92% (0.5368--0.8008)\<0.00010.757Microscopy253541.67%5314726.5%Table 10Test specifications.Table 10RDTSpecificationACON Malaria Pf/Pan test kitHRP-2 antigenAldolase antigenSD Bioline Malaria Ag Pf test KitHRP-2 AntigenTable 11Contingency tables for symptomatic cohort.Table 11MicroscopySD Bioline KitPositiveNegativePositive195Negative630MicroscopyACON Malaria Pf/Pan KitPositiveNegativePositive214Negative431Table 12Contingency tables for asymptomatic cohort.Table 12MicroscopySD Bioline KitPositiveNegativePositive340Negative19147MicroscopyACON Malaria Pf/Pan KitPositiveNegativePositive333Negative20144

2. Experimental design, materials, and methods {#s0010}
==============================================

Data was obtained between November, 2016 and May, 2017 from 260 participants, 200 asymptomatic and 60 symptomatic subjects attending the University Health Centre.

Blood samples for analysis were obtained using either of two methods; direct sampling via finger prick or venous blood collected into EDTA bottles. Tests were performed using two RDT kits (ACON Malaria P.f/ Pan Rapid Test Device and SD BIOLINE Malaria Ag P.f test kits) [@bib1], [@bib2], [@bib3], [@bib4], [@bib5]. Thick blood smears were prepared and stained with 10% Giemsa for 15 min to determine parasitemia which was estimated from the thick film by counting the number of parasites within 200 white blood cells (leukocyte) [@bib6], [@bib7].

The two-tailed Fisher׳s exact test (95% Confidence Interval) was used to check for significant differences in the sensitivities of the RDTs. Inter-test agreement for positive and negative results was expressed by the percentage of overall agreement. Kappa statistic (κ) was used to determine the agreement between malaria RDTs and the reference methods. κ-values 0.6--0.8 was considered as good while k-values \>0.8 were considered excellent.
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